Clinical Trial Update: Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating gemcitabine and mitoxantrone in relapsed acute myeloid leukemia; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2015-10-05